104.43 1.1 (1.06%) | 04-22 16:00 | |||||||||||||
|
|
Short term | ||||
Mid term | ||||
Targets | 6-month : | 136.81 | 1-year : | 147.92 |
Resists | First : | 117.13 | Second : | 126.65 |
Pivot price | 108.26 | |||
Supports | First : | 101.75 | Second : | 84.65 |
MAs | MA(5) : | 103.09 | MA(20) : | 111.86 |
MA(100) : | 110.37 | MA(250) : | 101.1 | |
MACD | MACD : | -4.5 | Signal : | -3.6 |
%K %D | K(14,3) : | 8.1 | D(3) : | 4.7 |
RSI | RSI(14): 33.9 | |||
52-week | High : | 127.5 | Low : | 75.38 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ CURE ] has closed above bottom band by 31.7%. Bollinger Bands are 62.7% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 10 days. This is a sign that the current trend might continue.
If tomorrow: | Open lower | Open higher |
High: | 106.91 - 107.32 | 107.32 - 107.79 |
Low: | 102.15 - 102.58 | 102.58 - 103.09 |
Close: | 103.62 - 104.32 | 104.32 - 105.13 |
The fund invests at least 80% of its net assets in financial instruments, such as swap agreements, securities of the index, and ETFs that track the index and other financial instruments that provide daily leveraged exposure to the index or to ETFs that track the index. The index includes domestic companies from the healthcare sector, which includes: pharmaceuticals; health care equipment and supplies; health care providers and services; biotechnology; life sciences tools and services; and etc. It is non-diversified.
Wed, 28 Feb 2024
Healthcare Showing That Big Tech Isn't the Only Bull in Town - ETF Trends
Wed, 20 Dec 2023
AI Adoption in Healthcare Spells Opportunity in 2 ETFs - ETF Trends
Tue, 28 Nov 2023
Top Performing Leveraged/Inverse ETFs: 11/26/2023 - ETF Trends
Tue, 11 Jul 2023
CURE: One Of Those Rare 3x Leveraged ETFs That Delivered Long-Term Returns - Seeking Alpha
Mon, 09 Jan 2023
3 Triple Leveraged ETFs Traders Can Consider in 2023 - ETF Trends
Thu, 24 Mar 2022
CURE: One Of The Best Performing 3X Shares ETF (NYSEARCA:CURE) - Seeking Alpha
Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
Exchange:
AMEX
|
|
Sector:
Financial Services
|
|
Industry:
Asset Management
|
|
Shares Out | 0 (M) |
Shares Float | 0 (M) |
Held by Insiders | 0 (%) |
Held by Institutions | 0 (%) |
Shares Short | 0 (K) |
Shares Short P.Month | 0 (K) |
EPS | 0 |
EPS Est Next Qtrly | 0 |
EPS Est This Year | 0 |
EPS Est Next Year | 0 |
Book Value (p.s.) | 0 |
Profit Margin | 0 % |
Operating Margin | 0 % |
Return on Assets (ttm) | 0 % |
Return on Equity (ttm) | 0 % |
Qtrly Rev. Growth | 0 % |
Gross Profit (p.s.) | 0 |
Sales Per Share | 0 |
EBITDA (p.s.) | 0 |
Qtrly Earnings Growth | 0 % |
Operating Cash Flow | 0 (M) |
Levered Free Cash Flow | 0 (M) |
PE Ratio | 0 |
PEG Ratio | 0 |
Price to Book value | 0 |
Price to Sales | 0 |
Price to Cash Flow | 0 |
Dividend | 0 |
Forward Dividend | 0 |
Dividend Yield | 0% |
Dividend Pay Date | Invalid DateTime. |
Ex-Dividend Date | Invalid DateTime. |